Ovid Therapeutics Inc. · NASDAQ:OVID
Rubric Capital Management LP's stake in Ovid Therapeutics Inc. fell to 0.67% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 9, 2025
Rubric Capital Management LP's stake in Ovid Therapeutics Inc. fell to 0.67%, 478,533 shares, as a passive investor on Jun 30, 2025. Filed Jul 9, 2025 (Schedule 13G/A).
- Stake
- 0.67%
- Shares
- 478,533
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Rubric Capital Management LP | 0.67% | 478,533 |
| David Rosen | 0.67% | 478,533 |
Source
Related
- Ovid Therapeutics Inc.
- Rubric Capital Management LP
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026